摘要
盐酸溴己新(1)是一种常用祛痰药,存在多晶型现象,晶型转变可能影响其药效。该研究采用红外光谱(IR)法、粉末X射线衍射(PXRD)分析和差示扫描量热(DSC)法对1颗粒和1分散片进行晶型表征,探究了其在制备和贮存过程中1的晶型稳定性。通过IR法和PXRD法可鉴别出1的3种不同晶型;而DSC法对不同晶型的特征区分不明显,不可用于1晶型表征。IR法和PXRD法分析结果显示,在颗粒、分散片的制备过程中,以及在高温、光照、高湿条件下贮存,晶型A均未发生晶型转变,稳定性良好。该研究为产品质量控制水平的提高和生产过程的监测提供了试验数据。
Bromhexine hydrochloride(1)is a commonly used expectorant,showing a polycrystalline phenomenon.Crystal transformation might affect its efficacy.Infrared spectroscopy(IR),powder X-ray diffraction(PXRD),and differential scanning calorimetry(DSC)analyses were adopted to characterize crystal patterns of 1 in its granules and dispersible tablets,and the crystal stability of 1 during the preparation and storage processes was studied.Through IR and PXRD analyses,three different crystal forms of 1 could be identified,while the characterization results of three different crystal forms by DSC were not remarkable.The results indicated that crystal form A of 1 showed good crystal stability and did not undergo crystal transformation during the preparation processes of granules and dispersible tablets or storage under high temperature,light,and high humidity conditions.This paper provided data for improving quality control levels and monitoring the production process.
作者
张韩一兰
胡宇华
张嵩
徐卫国
杨庆云
ZHANG Hanyilan;HU Yuhua;ZHANG Song;XU Weiguo;YANG Qingyun(State Key Lab.of Bioactive Substance and Function of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences&Peking Union Medical College,Beijing 100050;Jiangxi Yiyou Pharmaceutical Co.,Ltd.,Fuzhou 331800)
出处
《中国医药工业杂志》
CAS
CSCD
北大核心
2023年第7期1104-1111,共8页
Chinese Journal of Pharmaceuticals
基金
江西省重大科技研发专项(20203ABC28W017)。
关键词
盐酸溴己新
晶型
稳定性
颗粒
分散片
bromhexine hydrochloride
crystal form
stability
granule
dispersible tablet